Clinical Trials Insight: 700019981
Phase of Trial: Phase II
Latest Information Update: 10 Aug 2007
At a glance
- Drugs Eprotirome (Primary)
- Indications Dyslipidaemias; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Karo Bio
- 10 Aug 2007 Results from this study will be presented at the Drugs Affecting Lipid Metabolism (DALM) meeting in New York from 4-7 October 2007.
- 12 Jun 2007 Status changed from recruiting to completed.
- 22 Dec 2006 New trial record.